142 related articles for article (PubMed ID: 32234958)
1. Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety.
Grant BMM; Enomoto M; Back SI; Lee KY; Gebregiworgis T; Ishiyama N; Ikura M; Marshall CB
Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234958
[TBL] [Abstract][Full Text] [Related]
2. A Non-Canonical Calmodulin Target Motif Comprising a Polybasic Region and Lipidated Terminal Residue Regulates Localization.
Grant BMM; Enomoto M; Ikura M; Marshall CB
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326637
[TBL] [Abstract][Full Text] [Related]
3. The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin.
Jang H; Banerjee A; Marcus K; Makowski L; Mattos C; Gaponenko V; Nussinov R
Structure; 2019 Nov; 27(11):1647-1659.e4. PubMed ID: 31495533
[TBL] [Abstract][Full Text] [Related]
4. KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner.
Agamasu C; Ghirlando R; Taylor T; Messing S; Tran TH; Bindu L; Tonelli M; Nissley DV; McCormick F; Stephen AG
Biophys J; 2019 Mar; 116(6):1049-1063. PubMed ID: 30846362
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.
Dharmaiah S; Bindu L; Tran TH; Gillette WK; Frank PH; Ghirlando R; Nissley DV; Esposito D; McCormick F; Stephen AG; Simanshu DK
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6766-E6775. PubMed ID: 27791178
[TBL] [Abstract][Full Text] [Related]
6. Interaction of KRas4B protein with C6-ceramide containing lipid model membranes.
Li L; Dwivedi M; Erwin N; Möbitz S; Nussbaumer P; Winter R
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):1008-1014. PubMed ID: 29357287
[TBL] [Abstract][Full Text] [Related]
7. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.
Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R
J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325
[TBL] [Abstract][Full Text] [Related]
8. Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes.
Barklis E; Stephen AG; Staubus AO; Barklis RL; Alfadhli A
J Mol Biol; 2019 Sep; 431(19):3706-3717. PubMed ID: 31330153
[TBL] [Abstract][Full Text] [Related]
9. Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions.
Gillette WK; Esposito D; Abreu Blanco M; Alexander P; Bindu L; Bittner C; Chertov O; Frank PH; Grose C; Jones JE; Meng Z; Perkins S; Van Q; Ghirlando R; Fivash M; Nissley DV; McCormick F; Holderfield M; Stephen AG
Sci Rep; 2015 Nov; 5():15916. PubMed ID: 26522388
[TBL] [Abstract][Full Text] [Related]
10. Regulation of K-Ras4B Membrane Binding by Calmodulin.
Sperlich B; Kapoor S; Waldmann H; Winter R; Weise K
Biophys J; 2016 Jul; 111(1):113-22. PubMed ID: 27410739
[TBL] [Abstract][Full Text] [Related]
11. Both the C-terminal polylysine region and the farnesylation of K-RasB are important for its specific interaction with calmodulin.
Wu LJ; Xu LR; Liao JM; Chen J; Liang Y
PLoS One; 2011; 6(7):e21929. PubMed ID: 21750741
[TBL] [Abstract][Full Text] [Related]
12. Production and Membrane Binding of N-Terminally Acetylated, C-Terminally Farnesylated and Carboxymethylated KRAS4b.
Messing S; Agamasu C; Drew M; DeHart CJ; Stephen AG; Gillette WK
Methods Mol Biol; 2021; 2262():105-116. PubMed ID: 33977473
[TBL] [Abstract][Full Text] [Related]
13. Membrane interactions of the globular domain and the hypervariable region of KRAS4b define its unique diffusion behavior.
Goswami D; Chen D; Yang Y; Gudla PR; Columbus J; Worthy K; Rigby M; Wheeler M; Mukhopadhyay S; Powell K; Burgan W; Wall V; Esposito D; Simanshu DK; Lightstone FC; Nissley DV; McCormick F; Turbyville T
Elife; 2020 Jan; 9():. PubMed ID: 31958057
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution and characterization of BRAF in complex with 14-3-3 and KRAS4B on nanodiscs.
Liu NF; Enomoto M; Marshall CB; Ikura M
Protein Sci; 2024 Jun; 33(6):e5016. PubMed ID: 38747381
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.
Nussinov R; Zhang M; Tsai CJ; Jang H
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261
[TBL] [Abstract][Full Text] [Related]
16. PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b.
McLean MA; Stephen AG; Sligar SG
Biochemistry; 2019 Aug; 58(33):3537-3545. PubMed ID: 31339036
[TBL] [Abstract][Full Text] [Related]
17. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.
Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R
J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230
[TBL] [Abstract][Full Text] [Related]
18. K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function.
Cao S; Chung S; Kim S; Li Z; Manor D; Buck M
J Biol Chem; 2019 Apr; 294(17):7068-7084. PubMed ID: 30792310
[TBL] [Abstract][Full Text] [Related]
19. Exploring CRD mobility during RAS/RAF engagement at the membrane.
Nguyen K; López CA; Neale C; Van QN; Carpenter TS; Di Natale F; Travers T; Tran TH; Chan AH; Bhatia H; Frank PH; Tonelli M; Zhang X; Gulten G; Reddy T; Burns V; Oppelstrup T; Hengartner N; Simanshu DK; Bremer PT; Chen D; Glosli JN; Shrestha R; Turbyville T; Streitz FH; Nissley DV; Ingólfsson HI; Stephen AG; Lightstone FC; Gnanakaran S
Biophys J; 2022 Oct; 121(19):3630-3650. PubMed ID: 35778842
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the Dynamics of KRAS4b on Lipid Model Membranes.
López CA; Agarwal A; Van QN; Stephen AG; Gnanakaran S
J Membr Biol; 2021 Apr; 254(2):201-216. PubMed ID: 33825026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
